Bio Essence (BIOE) Cash & Current Investments (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Cash & Current Investments of $36177.0 in Q1 2026, up 25.87% quarter-over-quarter from $28741.0 in Q3 2025, and up 1708.85% on a YoY basis from $2000.0 in Q1 2025.
Bio Essence (BIOE) Cash & Current Investments (2020 - 2026) Analysis & Trends
Bio Essence's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $36177.0 for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 1708.85% year-over-year to $36177.0; the TTM figure through Mar 2026 stood at $36177.0 (changed N/A YoY), while the FY2024 annual figure was $3371.0, up 2857.02% from the prior year.
- Cash & Current Investments was $36177.0 for Q1 2026 at Bio Essence, up from $28741.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $36177.0 in Q1 2026 to a low of $23.0 in Q1 2024.
- Historically, Cash & Current Investments has averaged $7978.0 across 5 years, with a median of $572.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments plunged 98.53% in 2022, then soared 35650.56% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $6262.0 in 2022, then sank by 98.18% to $114.0 in 2023, then soared by 2857.02% to $3371.0 in 2024, then surged by 752.6% to $28741.0 in 2025, then rose by 25.87% to $36177.0 in 2026.
- The last three Cash & Current Investments figures came in at $36177.0 (Q1 2026), $28741.0 (Q3 2025), and $2000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | 36,177.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36,177.00 |
| Sep 30, 2025 | 28,741.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 3,371.00 |
| Sep 30, 2024 | 31,818.00 |
| Jun 30, 2024 | 9,489.00 |
| Mar 31, 2024 | 23.00 |
| Dec 31, 2023 | 114.00 |
| Sep 30, 2023 | 89.00 |
| Jun 30, 2023 | 541.00 |
| Mar 31, 2023 | 127.00 |
| Dec 31, 2022 | 6,262.00 |
| Sep 30, 2022 | 572.00 |
| Jun 30, 2022 | 121.00 |
| Mar 31, 2022 | 225.00 |
| Dec 31, 2021 | 303.00 |
| Sep 30, 2021 | 26,713.00 |
| Jun 30, 2021 | 8,222.00 |
| Mar 31, 2021 | 10,258.00 |
| Dec 31, 2020 | 5,325.00 |